http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100984376-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-128 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100984376-B1 |
| titleOfInvention | Cell delivery system for the cell therapy comprising cells derived from embryonic stem cells |
| abstract | The present invention provides a cell delivery system for cell therapy containing cells derived from embryonic stem cells, wherein the cell delivery system is formed by inserting cells derived from the embryonic stem cells into a carrier made of matrigel. To provide. The cell carrier is implanted in another site in the body where the disease site is not in direct contact; When the cell carrier is transplanted into a living body, the in vivo migration of cells derived from the embryonic stem cells from the transplantation site is inhibited by the carrier; Finally, it is removed from the transplant site. In the cell carrier of the present invention, a cell derived from an embryonic stem cell is achieved by achieving a cell therapeutic purpose with a substance such as a cytokine secreted by the cell in a state in which cells derived from an embryonic stem cell do not directly approach a disease site. Cancer, which can be caused by direct transplantation into a tumor, or problems with tumor formation can be excluded.n n n n Cell Carrier, Embryonic Stem Cells, Vascular Endothelial Cells |
| priorityDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.